Eslotin
(Desloratadine)




COMPOSITION

5 mg of syrup contain desloratadine 2.5 mg.

THERAPEUTIC INDICATIONS

- Urgent relief of seasonal allergic rhinitis symptoms like sneezing, nasal discharge, itch, nasal abstraction; eye itch;
- Lacrimation, red eyes and eye inflammatory; itch in palate, cough;
- Reduction and elimination of chronic idiopathic urticaria symptoms (itch and eruption).

CONTRAINDICATIONS

- Hypersensitivity to the ingredients of the medication;
- Pregnant women;
- Nursing mothers (breast feeding);
- Children under 2 years of age.

ADVERSE EFECTS

Possible side effects are the following: headache, seldom asthenia and fatigability, dry mouth.

DOSAGE AND ADMINISTRATION

Syrup is internally taken without regard to meals.
Adults and children 12 years of age and over take by 10 ml (5 mg) of syrup once daily.
Children 2 to 5 yeas of age are prescribed in dose 2,5 ml (1.25 mg) of syrup once daily.
Children 6 to 12 yeas of age – by 5 ml (2.5 mg) once daily.
For syrup proportioning cap is used which volume is 13 ml, graduated for 10 ml, 5 ml and 2.5 ml.

DRUG INTERACTIONS

In multiple joint application of desloratadine with ketoconazole, erythromycin, azithromycin, fluoxetine, cimetidine clinically significant changes of dezloratadine concentration in plasma were not detected.
Simultaneous meals intake does not influence on distribution of dezloratadine in body.
Desloratadine does not intensify alcohol action on central nerves system.

PREGNANCY AND LACTATION

Medication use at pregnancy and breast feeding is forbidden.

MANUFACTURED FORM

Syrup for internal use in bottle of dark glass 120 ml. 1 bottle in carton box with insert leaflet and proportioning cap.

Respiratory system

All Products
Aerolet Syrup
Brovensin
Budecton Capsul
Eslotin Syrup
Eslotin Tablet
Etacid
Foralec Capsul
Pefsal
Tirfens Tablet
Tirfens yrup
Ventacort

Home      |      Site Map      |      Terms of Use      |      Privacy Policy

2012 World Medicine. All Rights Reserved.